Miranda Jayne Toledano - Jan 1, 2022 Form 3 Insider Report for Entera Bio Ltd. (ENTX)

Role
Director
Signature
/s/ Dana Yaacov-Garbeli, Attorney-in-fact
Stock symbol
ENTX
Transactions as of
Jan 1, 2022
Transactions value $
$0
Form type
3
Date filed
1/11/2022, 03:07 PM
Previous filing
Jan 3, 2022
Next filing
Jan 19, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ENTX Stock Option (right to buy) Jan 1, 2022 Ordinary Shares, par value NIS 0.0000769 per share 33.6K $3.98 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options vested ratably on a quarterly basis over a three-year period that commenced on December 27, 2018.

Remarks:

See Exhibit 24.1 - Power of Attorney